{"id":"NCT00733135","sponsor":"Medtronic Endovascular","briefTitle":"Study of the SilverHawk™ /TurboHawk™ Plaque Excision Systems Used With SpiderFX to Treat Calcified Peripheral Arterial Disease (DEFINITIVE Ca++)","officialTitle":"Determination of Safety and Effectiveness of the SilverHawk™ Peripheral Plaque Excision System for Calcium (SilverHawk LS-C) and the SpiderFX™ Embolic Protection Device for the Treatment of Calcified Peripheral Arterial Disease in the Superficial Femoral and/or the Popliteal Arteries (DEFINITIVE Ca++)","status":"COMPLETED","phase":"PHASE2","dates":{"start":"2008-10","primaryCompletion":"2010-11","completion":"2010-11","firstPosted":"2008-08-12","resultsPosted":"2014-07-04","lastUpdate":"2015-08-26"},"enrollment":133,"design":{"allocation":"NON_RANDOMIZED","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Peripheral Arterial Disease"],"interventions":[{"type":"DEVICE","name":"SilverHawk™ LS-C, TurboHawk™ LS-C, TurboHawk™ LX-C plaque excision systems and SpiderFX™ embolic protection device","otherNames":[]}],"arms":[{"label":"Atherectomy with embolic protection","type":"OTHER"}],"summary":"This is a multi-center, non-randomized, single arm study of the SilverHawk™ /TurboHawk™ plaque excision systems when used in conjunction with SpiderFX™ embolic protection device in treatment of moderate to severely calcified peripheral arterial disease in the superficial femoral and/or popliteal arteries.","primaryOutcome":{"measure":"Successful Revascularization","timeFrame":"at the end of the procedure","effectByArm":[{"arm":"Study Cohort","deltaMin":92,"sd":null}],"pValues":[{"comp":"OG000","p":"<0.05"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":3},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["24402764"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":26,"n":133},"commonTop":["Dissection, grade A or B; target vessel","Other","Access site adverse event"]}}